ID   CATS_HUMAN              Reviewed;         331 AA.
AC   P25774; B4DWC9; D3DV05; Q5T5I0; Q6FHS5; Q9BUG3;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2006, sequence version 3.
DT   10-MAY-2017, entry version 176.
DE   RecName: Full=Cathepsin S;
DE            EC=3.4.22.27;
DE   Flags: Precursor;
GN   Name=CTSS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT THR-161.
RC   TISSUE=Alveolar macrophage;
RX   PubMed=1373132;
RA   Shi G.-P., Munger J.S., Meara J.P., Rich D.H., Chapman H.A.;
RT   "Molecular cloning and expression of human alveolar macrophage
RT   cathepsin S, an elastinolytic cysteine protease.";
RL   J. Biol. Chem. 267:7258-7262(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=1377692;
RA   Wiederanders B., Broemme D., Kirschke H., von Figura K., Schmidt B.,
RA   Peters C.;
RT   "Phylogenetic conservation of cysteine proteinases. Cloning and
RT   expression of a cDNA coding for human cathepsin S.";
RL   J. Biol. Chem. 267:13708-13713(1992).
RN   [3]
RP   SEQUENCE REVISION TO 211.
RA   Wiederanders B., Broemme D., Kirschke H., von Figura K., Schmidt B.,
RA   Peters C.;
RL   Submitted (MAY-1995) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT THR-161.
RX   PubMed=8157683;
RA   Shi G.-P., Webb A.C., Foster K.E., Knoll J.H.M., Lemere C.A.,
RA   Munger J.S., Chapman H.A.;
RT   "Human cathepsin S: chromosomal localization, gene structure, and
RT   tissue distribution.";
RL   J. Biol. Chem. 269:11530-11536(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   TRP-113.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   TRP-113.
RC   TISSUE=Placenta, and Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   TRP-113.
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [13]
RP   3D-STRUCTURE MODELING OF 115-331.
RX   PubMed=9876921; DOI=10.1093/protein/11.11.1007;
RA   Fengler A., Brandt W.;
RT   "Three-dimensional structures of the cysteine proteases cathepsins K
RT   and S deduced by knowledge-based modelling and active site
RT   characteristics.";
RL   Protein Eng. 11:1007-1013(1998).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 115-331.
RX   PubMed=11856830; DOI=10.1107/S0907444901021825;
RA   Turkenburg J.P., Lamers M.B., Brzozowski A.M., Wright L.M.,
RA   Hubbard R.E., Sturt S.L., Williams D.H.;
RT   "Structure of a Cys25-->Ser mutant of human cathepsin S.";
RL   Acta Crystallogr. D 58:451-455(2002).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 112-331 IN COMPLEX WITH
RP   INHIBITOR, AND DISULFIDE BONDS.
RX   PubMed=17469812; DOI=10.1021/jm070111+;
RA   Inagaki H., Tsuruoka H., Hornsby M., Lesley S.A., Spraggon G.,
RA   Ellman J.A.;
RT   "Characterization and optimization of selective, nonpeptidic
RT   inhibitors of cathepsin S with an unprecedented binding mode.";
RL   J. Med. Chem. 50:2693-2699(2007).
CC   -!- FUNCTION: Thiol protease. Key protease responsible for the removal
CC       of the invariant chain from MHC class II molecules. The bond-
CC       specificity of this proteinase is in part similar to the
CC       specificities of cathepsin L and cathepsin N.
CC   -!- CATALYTIC ACTIVITY: Similar to cathepsin L, but with much less
CC       activity on Z-Phe-Arg-|-NHMec, and more activity on the Z-Val-Val-
CC       Arg-|-Xaa compound.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:17469812}.
CC   -!- SUBCELLULAR LOCATION: Lysosome.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P25774-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P25774-2; Sequence=VSP_042712;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the peptidase C1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU10088, ECO:0000255|PROSITE-
CC       ProRule:PRU10089, ECO:0000255|PROSITE-ProRule:PRU10090}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S93414; AAB22005.1; -; mRNA.
DR   EMBL; M86553; AAA35655.1; -; mRNA.
DR   EMBL; M90696; AAC37592.1; -; mRNA.
DR   EMBL; U07374; AAB60643.2; -; Genomic_DNA.
DR   EMBL; U07370; AAB60643.2; JOINED; Genomic_DNA.
DR   EMBL; U07371; AAB60643.2; JOINED; Genomic_DNA.
DR   EMBL; U07372; AAB60643.2; JOINED; Genomic_DNA.
DR   EMBL; U07373; AAB60643.2; JOINED; Genomic_DNA.
DR   EMBL; CR541676; CAG46477.1; -; mRNA.
DR   EMBL; AK301472; BAG62991.1; -; mRNA.
DR   EMBL; AK314482; BAG37086.1; -; mRNA.
DR   EMBL; AL356292; CAI13657.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53518.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53519.1; -; Genomic_DNA.
DR   EMBL; BC002642; AAH02642.1; -; mRNA.
DR   CCDS; CCDS55634.1; -. [P25774-2]
DR   CCDS; CCDS968.1; -. [P25774-1]
DR   PIR; A42482; A42482.
DR   RefSeq; NP_001186668.1; NM_001199739.1. [P25774-2]
DR   RefSeq; NP_004070.3; NM_004079.4. [P25774-1]
DR   UniGene; Hs.181301; -.
DR   PDB; 1BXF; Model; -; A=115-331.
DR   PDB; 1GLO; X-ray; 2.20 A; A=115-331.
DR   PDB; 1MS6; X-ray; 1.90 A; A=115-331.
DR   PDB; 1NPZ; X-ray; 2.00 A; A/B=115-331.
DR   PDB; 1NQC; X-ray; 1.80 A; A=115-331.
DR   PDB; 2C0Y; X-ray; 2.10 A; A=17-331.
DR   PDB; 2F1G; X-ray; 1.90 A; A/B=112-331.
DR   PDB; 2FQ9; X-ray; 1.65 A; A/B=114-331.
DR   PDB; 2FRA; X-ray; 1.90 A; A/B=114-330.
DR   PDB; 2FRQ; X-ray; 1.60 A; A/B=114-331.
DR   PDB; 2FT2; X-ray; 1.70 A; A/B=114-331.
DR   PDB; 2FUD; X-ray; 1.95 A; A/B=114-331.
DR   PDB; 2FYE; X-ray; 2.20 A; A=115-331.
DR   PDB; 2G6D; X-ray; 2.50 A; A=115-331.
DR   PDB; 2G7Y; X-ray; 2.00 A; A/B=114-330.
DR   PDB; 2H7J; X-ray; 1.50 A; A/B=112-331.
DR   PDB; 2HH5; X-ray; 1.80 A; A/B=112-331.
DR   PDB; 2HHN; X-ray; 1.55 A; A/B=112-331.
DR   PDB; 2HXZ; X-ray; 1.90 A; A/B/C=112-331.
DR   PDB; 2OP3; X-ray; 1.60 A; A/B=112-331.
DR   PDB; 2R9M; X-ray; 1.97 A; A/B=115-331.
DR   PDB; 2R9N; X-ray; 2.00 A; A/B=115-331.
DR   PDB; 2R9O; X-ray; 2.00 A; A/B=115-331.
DR   PDB; 3IEJ; X-ray; 2.18 A; A/B=115-331.
DR   PDB; 3KWN; X-ray; 2.10 A; A/B=115-331.
DR   PDB; 3MPE; X-ray; 2.25 A; A/B=114-331.
DR   PDB; 3MPF; X-ray; 1.80 A; A/B=115-331.
DR   PDB; 3N3G; X-ray; 1.60 A; A/B=115-331.
DR   PDB; 3N4C; X-ray; 1.90 A; A/B=115-331.
DR   PDB; 3OVX; X-ray; 1.49 A; A/B=114-331.
DR   PDB; 4P6E; X-ray; 1.80 A; A/B=109-331.
DR   PDB; 4P6G; X-ray; 1.58 A; A/B/C/D=114-331.
DR   PDBsum; 1BXF; -.
DR   PDBsum; 1GLO; -.
DR   PDBsum; 1MS6; -.
DR   PDBsum; 1NPZ; -.
DR   PDBsum; 1NQC; -.
DR   PDBsum; 2C0Y; -.
DR   PDBsum; 2F1G; -.
DR   PDBsum; 2FQ9; -.
DR   PDBsum; 2FRA; -.
DR   PDBsum; 2FRQ; -.
DR   PDBsum; 2FT2; -.
DR   PDBsum; 2FUD; -.
DR   PDBsum; 2FYE; -.
DR   PDBsum; 2G6D; -.
DR   PDBsum; 2G7Y; -.
DR   PDBsum; 2H7J; -.
DR   PDBsum; 2HH5; -.
DR   PDBsum; 2HHN; -.
DR   PDBsum; 2HXZ; -.
DR   PDBsum; 2OP3; -.
DR   PDBsum; 2R9M; -.
DR   PDBsum; 2R9N; -.
DR   PDBsum; 2R9O; -.
DR   PDBsum; 3IEJ; -.
DR   PDBsum; 3KWN; -.
DR   PDBsum; 3MPE; -.
DR   PDBsum; 3MPF; -.
DR   PDBsum; 3N3G; -.
DR   PDBsum; 3N4C; -.
DR   PDBsum; 3OVX; -.
DR   PDBsum; 4P6E; -.
DR   PDBsum; 4P6G; -.
DR   ProteinModelPortal; P25774; -.
DR   SMR; P25774; -.
DR   BioGrid; 107900; 3.
DR   DIP; DIP-61077N; -.
DR   IntAct; P25774; 2.
DR   STRING; 9606.ENSP00000357981; -.
DR   BindingDB; P25774; -.
DR   ChEMBL; CHEMBL2954; -.
DR   DrugBank; DB08195; (1R)-2-[(CYANOMETHYL)AMINO]-1-({[2-(DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)-2-OXOETHYL MORPHOLINE-4-CARBOXYLATE.
DR   DrugBank; DB03837; Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide.
DR   DrugBank; DB03984; Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide.
DR   DrugBank; DB03767; Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide.
DR   DrugBank; DB08752; N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide.
DR   DrugBank; DB08755; N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide.
DR   GuidetoPHARMACOLOGY; 2353; -.
DR   MEROPS; I29.004; -.
DR   iPTMnet; P25774; -.
DR   PhosphoSitePlus; P25774; -.
DR   BioMuta; CTSS; -.
DR   DMDM; 88984046; -.
DR   EPD; P25774; -.
DR   MaxQB; P25774; -.
DR   PaxDb; P25774; -.
DR   PeptideAtlas; P25774; -.
DR   PRIDE; P25774; -.
DR   DNASU; 1520; -.
DR   Ensembl; ENST00000368985; ENSP00000357981; ENSG00000163131. [P25774-1]
DR   Ensembl; ENST00000448301; ENSP00000408414; ENSG00000163131. [P25774-2]
DR   GeneID; 1520; -.
DR   KEGG; hsa:1520; -.
DR   UCSC; uc001evn.3; human. [P25774-1]
DR   CTD; 1520; -.
DR   DisGeNET; 1520; -.
DR   GeneCards; CTSS; -.
DR   HGNC; HGNC:2545; CTSS.
DR   HPA; CAB000460; -.
DR   HPA; HPA002988; -.
DR   MIM; 116845; gene.
DR   neXtProt; NX_P25774; -.
DR   OpenTargets; ENSG00000163131; -.
DR   PharmGKB; PA27041; -.
DR   eggNOG; KOG1543; Eukaryota.
DR   eggNOG; COG4870; LUCA.
DR   GeneTree; ENSGT00760000118871; -.
DR   HOGENOM; HOG000230774; -.
DR   HOVERGEN; HBG011513; -.
DR   InParanoid; P25774; -.
DR   KO; K01368; -.
DR   OMA; KATDQKC; -.
DR   OrthoDB; EOG091G0AKT; -.
DR   PhylomeDB; P25774; -.
DR   TreeFam; TF313739; -.
DR   BRENDA; 3.4.22.27; 2681.
DR   Reactome; R-HSA-1236977; Endosomal/Vacuolar pathway.
DR   Reactome; R-HSA-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-HSA-1679131; Trafficking and processing of endosomal TLR.
DR   Reactome; R-HSA-2022090; Assembly of collagen fibrils and other multimeric structures.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   ChiTaRS; CTSS; human.
DR   EvolutionaryTrace; P25774; -.
DR   GeneWiki; Cathepsin_S; -.
DR   GenomeRNAi; 1520; -.
DR   PMAP-CutDB; P25774; -.
DR   PRO; PR:P25774; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000163131; -.
DR   CleanEx; HS_CTSS; -.
DR   ExpressionAtlas; P25774; baseline and differential.
DR   Genevisible; P25774; HS.
DR   GO; GO:0036021; C:endolysosome lumen; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0005764; C:lysosome; IDA:UniProtKB.
DR   GO; GO:1904724; C:tertiary granule lumen; TAS:Reactome.
DR   GO; GO:0005518; F:collagen binding; IDA:BHF-UCL.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IDA:CAFA.
DR   GO; GO:0001968; F:fibronectin binding; IPI:BHF-UCL.
DR   GO; GO:0043236; F:laminin binding; IDA:BHF-UCL.
DR   GO; GO:0043394; F:proteoglycan binding; IPI:BHF-UCL.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; TAS:Reactome.
DR   GO; GO:0002250; P:adaptive immune response; IEP:UniProtKB.
DR   GO; GO:0019882; P:antigen processing and presentation; TAS:UniProtKB.
DR   GO; GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome.
DR   GO; GO:0048002; P:antigen processing and presentation of peptide antigen; IDA:CACAO.
DR   GO; GO:0034769; P:basement membrane disassembly; IDA:BHF-UCL.
DR   GO; GO:0097067; P:cellular response to thyroid hormone stimulus; IEP:UniProtKB.
DR   GO; GO:0030574; P:collagen catabolic process; IDA:BHF-UCL.
DR   GO; GO:0022617; P:extracellular matrix disassembly; TAS:Reactome.
DR   GO; GO:0006955; P:immune response; TAS:ProtInc.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:2001259; P:positive regulation of cation channel activity; IDA:CACAO.
DR   GO; GO:0016485; P:protein processing; IDA:CACAO.
DR   GO; GO:0006508; P:proteolysis; IDA:CAFA.
DR   GO; GO:0051603; P:proteolysis involved in cellular protein catabolic process; IDA:BHF-UCL.
DR   GO; GO:0010447; P:response to acidic pH; IDA:CACAO.
DR   GO; GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome.
DR   InterPro; IPR025661; Pept_asp_AS.
DR   InterPro; IPR000169; Pept_cys_AS.
DR   InterPro; IPR025660; Pept_his_AS.
DR   InterPro; IPR013128; Peptidase_C1A.
DR   InterPro; IPR000668; Peptidase_C1A_C.
DR   InterPro; IPR013201; Prot_inhib_I29.
DR   PANTHER; PTHR12411; PTHR12411; 1.
DR   Pfam; PF08246; Inhibitor_I29; 1.
DR   Pfam; PF00112; Peptidase_C1; 1.
DR   PRINTS; PR00705; PAPAIN.
DR   SMART; SM00848; Inhibitor_I29; 1.
DR   SMART; SM00645; Pept_C1; 1.
DR   PROSITE; PS00640; THIOL_PROTEASE_ASN; 1.
DR   PROSITE; PS00139; THIOL_PROTEASE_CYS; 1.
DR   PROSITE; PS00639; THIOL_PROTEASE_HIS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Disulfide bond;
KW   Glycoprotein; Hydrolase; Lysosome; Polymorphism; Protease;
KW   Reference proteome; Signal; Thiol protease; Zymogen.
FT   SIGNAL        1     16       {ECO:0000255}.
FT   PROPEP       17    114       Activation peptide.
FT                                /FTId=PRO_0000026313.
FT   CHAIN       115    331       Cathepsin S.
FT                                /FTId=PRO_0000026314.
FT   ACT_SITE    139    139       {ECO:0000250}.
FT   ACT_SITE    278    278       {ECO:0000250}.
FT   ACT_SITE    298    298       {ECO:0000250}.
FT   CARBOHYD    104    104       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    126    224       {ECO:0000269|PubMed:17469812}.
FT   DISULFID    136    180       {ECO:0000269|PubMed:17469812}.
FT   DISULFID    170    213       {ECO:0000269|PubMed:17469812}.
FT   DISULFID    272    320       {ECO:0000269|PubMed:17469812}.
FT   VAR_SEQ      84    133       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042712.
FT   VARIANT     113    113       R -> W (in dbSNP:rs2230061).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_025385.
FT   VARIANT     161    161       S -> T (in dbSNP:rs1059604).
FT                                {ECO:0000269|PubMed:1373132,
FT                                ECO:0000269|PubMed:8157683}.
FT                                /FTId=VAR_025386.
FT   CONFLICT     92     92       M -> T (in Ref. 1 and 4). {ECO:0000305}.
FT   HELIX        22     24       {ECO:0000244|PDB:2C0Y}.
FT   HELIX        25     35       {ECO:0000244|PDB:2C0Y}.
FT   HELIX        44     67       {ECO:0000244|PDB:2C0Y}.
FT   STRAND       72     75       {ECO:0000244|PDB:2C0Y}.
FT   HELIX        79     82       {ECO:0000244|PDB:2C0Y}.
FT   HELIX        85     91       {ECO:0000244|PDB:2C0Y}.
FT   HELIX       100    102       {ECO:0000244|PDB:2C0Y}.
FT   HELIX       121    124       {ECO:0000244|PDB:3OVX}.
FT   STRAND      135    137       {ECO:0000244|PDB:2HH5}.
FT   HELIX       139    156       {ECO:0000244|PDB:3OVX}.
FT   HELIX       164    170       {ECO:0000244|PDB:3OVX}.
FT   HELIX       173    175       {ECO:0000244|PDB:3OVX}.
FT   HELIX       179    181       {ECO:0000244|PDB:3OVX}.
FT   HELIX       185    195       {ECO:0000244|PDB:3OVX}.
FT   STRAND      198    200       {ECO:0000244|PDB:3OVX}.
FT   TURN        201    203       {ECO:0000244|PDB:3OVX}.
FT   HELIX       217    219       {ECO:0000244|PDB:3OVX}.
FT   STRAND      220    222       {ECO:0000244|PDB:3OVX}.
FT   STRAND      226    229       {ECO:0000244|PDB:3OVX}.
FT   HELIX       235    244       {ECO:0000244|PDB:3OVX}.
FT   STRAND      248    252       {ECO:0000244|PDB:3OVX}.
FT   HELIX       257    261       {ECO:0000244|PDB:3OVX}.
FT   STRAND      264    267       {ECO:0000244|PDB:3OVX}.
FT   STRAND      278    288       {ECO:0000244|PDB:3OVX}.
FT   STRAND      291    297       {ECO:0000244|PDB:3OVX}.
FT   TURN        301    303       {ECO:0000244|PDB:3MPE}.
FT   STRAND      309    313       {ECO:0000244|PDB:3OVX}.
FT   STRAND      315    318       {ECO:0000244|PDB:3OVX}.
FT   HELIX       319    321       {ECO:0000244|PDB:3OVX}.
FT   TURN        322    324       {ECO:0000244|PDB:3OVX}.
FT   STRAND      327    330       {ECO:0000244|PDB:3OVX}.
SQ   SEQUENCE   331 AA;  37496 MW;  86093619DB6F0269 CRC64;
     MKRLVCVLLV CSSAVAQLHK DPTLDHHWHL WKKTYGKQYK EKNEEAVRRL IWEKNLKFVM
     LHNLEHSMGM HSYDLGMNHL GDMTSEEVMS LMSSLRVPSQ WQRNITYKSN PNRILPDSVD
     WREKGCVTEV KYQGSCGACW AFSAVGALEA QLKLKTGKLV SLSAQNLVDC STEKYGNKGC
     NGGFMTTAFQ YIIDNKGIDS DASYPYKAMD QKCQYDSKYR AATCSKYTEL PYGREDVLKE
     AVANKGPVSV GVDARHPSFF LYRSGVYYEP SCTQNVNHGV LVVGYGDLNG KEYWLVKNSW
     GHNFGEEGYI RMARNKGNHC GIASFPSYPE I
//
